cisapride has been researched along with Gastroparesis in 41 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Gastroparesis: Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy of the herbal preparation STW 5 (Iberogast ((R))) and the research preparation STW 5-II with cisapride for treatment of patients with dysmotility type of functional dyspepsia." | 9.10 | A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. ( Rösch, W; Sassin, I; Vinson, B, 2002) |
| "Half emptying times in nine patients with diabetic gastroparesis were significantly shortened by cisapride (175 +/- 46 min vs." | 9.10 | Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control. ( Braden, B; Caspary, WF; Enghofer, M; Lembcke, B; Schaub, M; Usadel, KH, 2002) |
| "The effect of cisapride on gastric emptying, at least that of liquids, in patients with diabetic gastroparesis appears to be dependent on the plasma glucose concentration." | 9.10 | Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis. ( Harding, PE; Horowitz, M; Jones, KL; Wishart, JM, 2002) |
| "To assess the effect of an 8-week course of domperidone or cisapride on gastric electrical activity, gastric emptying time and dyspeptic symptoms in children with insulin-dependent diabetes mellitus and gastroparesis." | 9.10 | Domperidone is more effective than cisapride in children with diabetic gastroparesis. ( Borrelli, O; Corrado, G; Cucchiara, S; Di Nardo, G; Dito, L; Franzese, A; Grandinetti, AL; Rea, P, 2002) |
| "To compare the effects of chronic oral administration of cisapride and levosulpiride in patients with functional dyspepsia and delayed gastric emptying." | 9.09 | Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. ( Biagini, R; Borro, P; Giacomini, M; Mansi, C; Mele, MR; Pandolfo, N; Savarino, V, 2000) |
| "We conclude that cisapride-induced acceleration of liquid gastric emptying in diabetic gastroparesis does not appear to result from changes in antral contractility, but may be related to changes in proximal gastric tone or gastric outlet resistance." | 9.09 | Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride. ( Boesiger, P; Borovicka, J; Crelier, G; Fraser, R; Fried, M; Kreiss, C; Kunz, P; Lehmann, R; Schwizer, W; Spinas, GA, 1999) |
| " The aim of this study was to compare the effect of EM574 with that of cisapride on gastric motility and emptying in normal and gastroparesis dogs." | 7.70 | Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs. ( Itoh, Z; Mizumoto, A; Mochiki, E; Omura, S; Suzuki, H; Tanaka, T, 1998) |
| "Erythromycin, a macrolide antibiotic, has been shown to have gastric prokinetic effects and has been proposed as an alternative therapeutic option for diabetic gastroparesis." | 7.69 | Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. ( Andriulli, A; Annese, V; Bassotti, G; Frusciante, V; Germani, U; Lombardi, G, 1997) |
| " Chronic administration of a prokinetic drug resulted in improved solid gastric emptying (percentage residual) at 120 min (p=0." | 6.71 | Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug. ( Feinle, C; Fried, M; Honegger, RA; Lehmann, R; Schwizer, W; Spinas, GA, 2003) |
| " Domperidone is safer, although caution has to be paid in long-term use because of potential ventricular arrythmies." | 6.48 | [Management of gastroparesis and functional dyspepsia after cisapride withdrawal]. ( Louis, H, 2012) |
| " We conclude that long-term administration of cisapride reduced dysmotility symptoms and improved solid and liquid gastric emptying without adversely affecting glycemic control." | 5.29 | [Influence on glycemic control of improved diabetic gastroparesis by long-term cisapride therapy]. ( Ishii, K; Mitsuhashi, T; Saigenji, K; Tanabe, S, 1995) |
| "Cisapride is a newer prokinetic agent without side effects on the central nervous system and might be a superior treatment." | 5.29 | Cisapride as a treatment for gastroparesis in traumatic brain injury. ( Altmayer, T; Hawkins, HH; Jones, M; Martin, V; O'Dell, MW, 1996) |
| "Half emptying times in nine patients with diabetic gastroparesis were significantly shortened by cisapride (175 +/- 46 min vs." | 5.10 | Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control. ( Braden, B; Caspary, WF; Enghofer, M; Lembcke, B; Schaub, M; Usadel, KH, 2002) |
| "The effect of cisapride on gastric emptying, at least that of liquids, in patients with diabetic gastroparesis appears to be dependent on the plasma glucose concentration." | 5.10 | Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis. ( Harding, PE; Horowitz, M; Jones, KL; Wishart, JM, 2002) |
| "To assess the effect of an 8-week course of domperidone or cisapride on gastric electrical activity, gastric emptying time and dyspeptic symptoms in children with insulin-dependent diabetes mellitus and gastroparesis." | 5.10 | Domperidone is more effective than cisapride in children with diabetic gastroparesis. ( Borrelli, O; Corrado, G; Cucchiara, S; Di Nardo, G; Dito, L; Franzese, A; Grandinetti, AL; Rea, P, 2002) |
| "To compare the efficacy of the herbal preparation STW 5 (Iberogast ((R))) and the research preparation STW 5-II with cisapride for treatment of patients with dysmotility type of functional dyspepsia." | 5.10 | A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. ( Rösch, W; Sassin, I; Vinson, B, 2002) |
| "To compare the effects of chronic oral administration of cisapride and levosulpiride in patients with functional dyspepsia and delayed gastric emptying." | 5.09 | Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. ( Biagini, R; Borro, P; Giacomini, M; Mansi, C; Mele, MR; Pandolfo, N; Savarino, V, 2000) |
| "We conclude that cisapride-induced acceleration of liquid gastric emptying in diabetic gastroparesis does not appear to result from changes in antral contractility, but may be related to changes in proximal gastric tone or gastric outlet resistance." | 5.09 | Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride. ( Boesiger, P; Borovicka, J; Crelier, G; Fraser, R; Fried, M; Kreiss, C; Kunz, P; Lehmann, R; Schwizer, W; Spinas, GA, 1999) |
| "In conclusion, this study showed that cisapride can improve gastric dysrhythmia during both fasting and post-meal phases in patients with diabetic gastroparesis." | 5.08 | Effect of cisapride on gastric dysrhythmia and emptying of indigestible solids in type-II diabetic patients. ( Chang, CS; Chen, GH; Lien, HC; Poon, SK; Tung, CF; Yeh, HZ, 1998) |
| "The treatment of gastroparesis recently received a heavy blow from the restrictions on the use of the prokinetic drug cisapride, but, fortunately, at the same time, a nonpharmacological approach, such as gastric electrical stimulation, came up again with new techniques." | 4.81 | The "electrical way" to cure gastroparesis. ( Bortolotti, M, 2002) |
| "For the drug treatment of gastroparesis, domperidone, metoclopramide and cisapride may be prescribed as prokinetics." | 4.80 | [Treatment of severely delayed gastric emptying]. ( Gooszen, HG; Samsom, M, 2000) |
| " The aim of this study was to compare the effect of EM574 with that of cisapride on gastric motility and emptying in normal and gastroparesis dogs." | 3.70 | Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs. ( Itoh, Z; Mizumoto, A; Mochiki, E; Omura, S; Suzuki, H; Tanaka, T, 1998) |
| "The gastroprokinetic effects of de(N-methyl)-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal (EM574), a non-peptide motilin receptor agonist, were investigated in conscious dogs in a normal state and with experimentally-induced gastroparesis." | 3.70 | EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs. ( Inatomi, N; Itoh, Z; Marui, S; Omura, S; Sato, F, 2000) |
| "Erythromycin, a macrolide antibiotic, has been shown to have gastric prokinetic effects and has been proposed as an alternative therapeutic option for diabetic gastroparesis." | 3.69 | Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. ( Andriulli, A; Annese, V; Bassotti, G; Frusciante, V; Germani, U; Lombardi, G, 1997) |
| "To provide a transparent meta-analysis update to elucidate the association between symptom improvement and acceleration of GE due to gastroprokinetic agents available for long-term use in patients with gastroparesis." | 3.01 | Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence. ( Carbone, F; Goelen, N; Huang, IH; Janssen, P; Jones, M; Tack, J, 2023) |
| "At baseline conditions IDDM and PSS patients exhibited reduced gastric peristalsis and delayed emptying compared to controls." | 2.71 | Prokinetic therapy: what can be measured by gastric scintigraphy? ( Folwaczny, C; Linke, R; Meier, M; Muenzing, W; Schnell, O; Tatsch, K, 2005) |
| " Chronic administration of a prokinetic drug resulted in improved solid gastric emptying (percentage residual) at 120 min (p=0." | 2.71 | Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug. ( Feinle, C; Fried, M; Honegger, RA; Lehmann, R; Schwizer, W; Spinas, GA, 2003) |
| " Domperidone is safer, although caution has to be paid in long-term use because of potential ventricular arrythmies." | 2.48 | [Management of gastroparesis and functional dyspepsia after cisapride withdrawal]. ( Louis, H, 2012) |
| "During childhood, gastroparesis is quite rare, and is mostly seen in preterm infants, with either immaturity of the gastrointestinal tract, or when allergic to cow's milk protein." | 2.42 | Current pharmacological treatment of gastroparesis. ( Hauser, B; Salvatore, S; Vandenplas, Y, 2004) |
| " The appropriate use of prokinetic agents in these groups requires an understanding of the unique dosage considerations that may be necessary to ensure safe, effective therapy." | 2.39 | Use of prokinetic agents in special populations. ( Horn, JR, 1996) |
| " Cisapride (1, 3 and 10 mg/kg) caused non-significant increases in the indices of gastric emptying, with roughly bell-shaped dose-response curves." | 1.35 | Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs. ( Akima, M; Itoh, Z; Kamei, K; Koga, H; Omura, S; Onoma, M; Ozaki, K; Takanashi, H; Yogo, K, 2008) |
| "Cisapride is a newer prokinetic agent without side effects on the central nervous system and might be a superior treatment." | 1.29 | Cisapride as a treatment for gastroparesis in traumatic brain injury. ( Altmayer, T; Hawkins, HH; Jones, M; Martin, V; O'Dell, MW, 1996) |
| " We conclude that long-term administration of cisapride reduced dysmotility symptoms and improved solid and liquid gastric emptying without adversely affecting glycemic control." | 1.29 | [Influence on glycemic control of improved diabetic gastroparesis by long-term cisapride therapy]. ( Ishii, K; Mitsuhashi, T; Saigenji, K; Tanabe, S, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (36.59) | 18.2507 |
| 2000's | 18 (43.90) | 29.6817 |
| 2010's | 7 (17.07) | 24.3611 |
| 2020's | 1 (2.44) | 2.80 |
| Authors | Studies |
|---|---|
| Goelen, N | 1 |
| Jones, M | 3 |
| Huang, IH | 1 |
| Carbone, F | 1 |
| Janssen, P | 2 |
| Tack, J | 2 |
| Asha, MZ | 1 |
| Khalil, SFH | 1 |
| Kim, KH | 1 |
| Lee, MS | 1 |
| Choi, TY | 1 |
| Kim, TH | 1 |
| Vijayvargiya, P | 1 |
| Camilleri, M | 1 |
| Chedid, V | 1 |
| Mandawat, A | 1 |
| Erwin, PJ | 1 |
| Murad, MH | 1 |
| Harris, MS | 1 |
| Masaoka, T | 1 |
| Farré, R | 1 |
| Törnblom, H | 1 |
| Van Oudenhove, L | 1 |
| Simrén, M | 1 |
| Schmitz, S | 1 |
| Fink, T | 1 |
| Failing, K | 1 |
| Borsch, C | 1 |
| Kunz, C | 1 |
| Clemence, R | 1 |
| Savary-Bataille, K | 1 |
| Neiger, R | 1 |
| Quigley, EM | 1 |
| Louis, H | 1 |
| Braden, B | 1 |
| Enghofer, M | 1 |
| Schaub, M | 1 |
| Usadel, KH | 1 |
| Caspary, WF | 1 |
| Lembcke, B | 1 |
| Bortolotti, M | 1 |
| Lehmann, R | 2 |
| Honegger, RA | 1 |
| Feinle, C | 2 |
| Fried, M | 2 |
| Spinas, GA | 2 |
| Schwizer, W | 2 |
| Melga, P | 1 |
| Mansi, C | 2 |
| Vandenplas, Y | 1 |
| Hauser, B | 1 |
| Salvatore, S | 1 |
| Linke, R | 1 |
| Meier, M | 1 |
| Muenzing, W | 1 |
| Folwaczny, C | 1 |
| Schnell, O | 1 |
| Tatsch, K | 1 |
| Onoma, M | 1 |
| Yogo, K | 1 |
| Ozaki, K | 1 |
| Kamei, K | 1 |
| Akima, M | 1 |
| Koga, H | 1 |
| Itoh, Z | 3 |
| Omura, S | 3 |
| Takanashi, H | 1 |
| Olausson, EA | 1 |
| Alpsten, M | 1 |
| Larsson, A | 1 |
| Mattsson, H | 1 |
| Andersson, H | 1 |
| Attvall, S | 1 |
| Ishii, K | 1 |
| Tanabe, S | 1 |
| Mitsuhashi, T | 1 |
| Saigenji, K | 1 |
| Read, SJ | 1 |
| Leggett, BA | 1 |
| Pender, MP | 1 |
| Jia, B | 1 |
| Cucchiara, S | 2 |
| Altmayer, T | 1 |
| O'Dell, MW | 1 |
| Martin, V | 1 |
| Hawkins, HH | 1 |
| Horn, JR | 1 |
| Prassler, R | 1 |
| Huchzermeyer, H | 1 |
| Annese, V | 1 |
| Lombardi, G | 1 |
| Frusciante, V | 1 |
| Germani, U | 1 |
| Andriulli, A | 1 |
| Bassotti, G | 1 |
| Yamano, M | 2 |
| Kamato, T | 1 |
| Nagakura, Y | 1 |
| Miyata, K | 1 |
| Sigurdsson, L | 1 |
| Flores, A | 1 |
| Putnam, PE | 1 |
| Hyman, PE | 1 |
| Di Lorenzo, C | 1 |
| Hep, A | 1 |
| Prásek, J | 1 |
| Filipínský, J | 1 |
| Navrátil, P | 1 |
| David, L | 1 |
| Dolina, J | 1 |
| Dítĕ, P | 1 |
| Chang, CS | 1 |
| Lien, HC | 1 |
| Yeh, HZ | 1 |
| Poon, SK | 1 |
| Tung, CF | 1 |
| Chen, GH | 1 |
| Chye, R | 1 |
| Tanaka, T | 1 |
| Mizumoto, A | 1 |
| Mochiki, E | 1 |
| Suzuki, H | 1 |
| Borovicka, J | 1 |
| Kunz, P | 1 |
| Fraser, R | 1 |
| Kreiss, C | 1 |
| Crelier, G | 1 |
| Boesiger, P | 1 |
| Borro, P | 1 |
| Giacomini, M | 1 |
| Biagini, R | 1 |
| Mele, MR | 1 |
| Pandolfo, N | 1 |
| Savarino, V | 1 |
| Sato, F | 1 |
| Marui, S | 1 |
| Inatomi, N | 1 |
| Zaloga, GP | 1 |
| Marik, P | 1 |
| von Ehrlich, B | 1 |
| Samsom, M | 2 |
| Gooszen, HG | 1 |
| Takeda, M | 1 |
| Mizutani, Y | 1 |
| Tsukamoto, K | 1 |
| Suzuki, T | 1 |
| Horowitz, M | 2 |
| O'Donovan, D | 1 |
| Jones, KL | 2 |
| Rayner, CK | 1 |
| Harding, PE | 1 |
| Wishart, JM | 1 |
| Franzese, A | 1 |
| Borrelli, O | 1 |
| Corrado, G | 1 |
| Rea, P | 1 |
| Di Nardo, G | 1 |
| Grandinetti, AL | 1 |
| Dito, L | 1 |
| Rösch, W | 1 |
| Vinson, B | 1 |
| Sassin, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot, Randomized, Double-blind, Placebo-controlled Trial of Promethazine for Treatment of Diabetic Gastroparesis.[NCT02130622] | Phase 2 | 3 participants (Actual) | Interventional | 2014-07-31 | Terminated (stopped due to Lack of recruitment) | ||
| Impact of Preoperative Oral Carbohydrate on Recovery in Diabetic Patients After Gastrointestinal Surgery: a Pilot Randomized Controlled Trial[NCT03204344] | 65 participants (Actual) | Interventional | 2017-08-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for cisapride and Gastroparesis
| Article | Year |
|---|---|
Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence.
Topics: Cisapride; Dyspepsia; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Humans | 2023 |
Pharmacological Approaches to Diabetic Gastroparesis: A systematic review of randomised clinical trials.
Topics: Antiemetics; Cisapride; Diabetes Complications; Domperidone; Gastric Emptying; Gastrointestinal Agen | 2019 |
Acupuncture for symptomatic gastroparesis.
Topics: Acupuncture Therapy; Benzamides; Cimetidine; Cisapride; Diabetes Complications; Domperidone; Gastroi | 2018 |
Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis.
Topics: Breath Tests; Cisapride; Domperidone; Dopamine D2 Receptor Antagonists; Dyspepsia; Gastric Emptying; | 2019 |
The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.
Topics: Cisapride; Diabetes Mellitus, Type 2; Domperidone; Erythromycin; Gastric Emptying; Gastrointestinal | 2013 |
Cisapride: what can we learn from the rise and fall of a prokinetic?
Topics: Cisapride; Gastroesophageal Reflux; Gastrointestinal Diseases; Gastrointestinal Motility; Gastropare | 2011 |
[Management of gastroparesis and functional dyspepsia after cisapride withdrawal].
Topics: Cisapride; Dyspepsia; Gastrointestinal Agents; Gastroparesis; Humans; Kinetics; Patient Selection; S | 2012 |
The "electrical way" to cure gastroparesis.
Topics: Animals; Cisapride; Electric Stimulation Therapy; Gastrointestinal Agents; Gastroparesis; Humans; St | 2002 |
Current pharmacological treatment of gastroparesis.
Topics: Adult; Child; Cisapride; Domperidone; Erythromycin; Gastrointestinal Agents; Gastroparesis; Humans; | 2004 |
Cisapride therapy for gastrointestinal disease.
Topics: Adult; Animals; Child; Cisapride; Constipation; Esophageal Motility Disorders; Gastrointestinal Dise | 1996 |
Use of prokinetic agents in special populations.
Topics: Age Factors; Cisapride; Drug Interactions; Gastroesophageal Reflux; Gastrointestinal Agents; Gastroi | 1996 |
Promotility agents in the intensive care unit.
Topics: Cisapride; Enteral Nutrition; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Gast | 2000 |
[Treatment of severely delayed gastric emptying].
Topics: Cisapride; Diagnosis, Differential; Digestive System Surgical Procedures; Domperidone; Dyspepsia; El | 2000 |
Gastric emptying in diabetes: clinical significance and treatment.
Topics: Blood Glucose; Cisapride; Diabetes Mellitus; Diabetic Neuropathies; Domperidone; Gastric Emptying; G | 2002 |
12 trials available for cisapride and Gastroparesis
| Article | Year |
|---|---|
Effects of the neurokinin-1 antagonist maropitant on canine gastric emptying assessed by radioscintigraphy and breath test.
Topics: Animals; Breath Tests; Cisapride; Cross-Over Studies; Dog Diseases; Dogs; Gastric Emptying; Gastroin | 2016 |
Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control.
Topics: Aged; Blood Glucose; Breath Tests; Cisapride; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug | 2002 |
Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
Topics: Adult; Age of Onset; Blood Glucose; Body Constitution; Cisapride; Diabetes Mellitus, Type 1; Diabeti | 2003 |
Type 1 (insulin-dependent) diabetes mellitus and gastric emptying: role of blood glucose concentration and dopamine D2 receptors.
Topics: Adult; Blood Glucose; Breath Tests; Cisapride; Cross-Over Studies; Diabetes Mellitus, Type 1; Female | 2004 |
Prokinetic therapy: what can be measured by gastric scintigraphy?
Topics: Adult; Aged; Cisapride; Diabetes Mellitus, Type 1; Female; Gastric Emptying; Gastrointestinal Agents | 2005 |
[Cisapride (Prepulsid) in the prevention of postoperative gastrointestinal atony].
Topics: Cisapride; Female; Gastrointestinal Agents; Gastrointestinal Motility; Gastroparesis; Humans; Male; | 1998 |
Effect of cisapride on gastric dysrhythmia and emptying of indigestible solids in type-II diabetic patients.
Topics: Blood Glucose; Cisapride; Diabetes Mellitus, Type 2; Female; Gastric Emptying; Gastrointestinal Agen | 1998 |
Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride.
Topics: Adult; Cisapride; Cross-Over Studies; Diabetic Neuropathies; Double-Blind Method; Female; Gastric Em | 1999 |
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
Topics: Activities of Daily Living; Administration, Oral; Adult; Aged; Anti-Ulcer Agents; Cisapride; Cross-O | 2000 |
Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis.
Topics: Adult; Blood Glucose; Cisapride; Diabetes Mellitus, Type 1; Female; Gastric Emptying; Gastrointestin | 2002 |
Domperidone is more effective than cisapride in children with diabetic gastroparesis.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Cisapride; Diabetes Mellitus, Type 1; Dom | 2002 |
A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
Topics: Adult; Aged; Cisapride; Double-Blind Method; Dyspepsia; Female; Gastroparesis; Humans; Male; Middle | 2002 |
15 other studies available for cisapride and Gastroparesis
| Article | Year |
|---|---|
Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
Topics: Acetaminophen; Administration, Oral; Animals; Cisapride; Clonidine; Disease Models, Animal; Dogs; Do | 2008 |
Small particle size of a solid meal increases gastric emptying and late postprandial glycaemic response in diabetic subjects with gastroparesis.
Topics: Aged; Blood Glucose; Cisapride; Diabetes Mellitus, Type 1; Diet, Diabetic; Eating; Female; Gastric E | 2008 |
[Influence on glycemic control of improved diabetic gastroparesis by long-term cisapride therapy].
Topics: Adult; Aged; Blood Glucose; Cisapride; Diabetes Complications; Diabetes Mellitus; Female; Gastric Em | 1995 |
Gastroparesis with multiple sclerosis.
Topics: Cisapride; Female; Gastric Emptying; Gastroparesis; Humans; Middle Aged; Multiple Sclerosis; Parasym | 1995 |
[Drug therapy of gastrointestinal motility disorders].
Topics: Cisapride; Domperidone; Dyspepsia; Gastroesophageal Reflux; Gastroparesis; Humans; Metoclopramide; P | 1995 |
Cisapride as a treatment for gastroparesis in traumatic brain injury.
Topics: Adult; Brain Injuries; Cisapride; Enteral Nutrition; Gastric Emptying; Gastroparesis; Humans; Male; | 1996 |
[Possibilities of ultrasonography of gastric emptying].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cisapride; Diabetic Neuropathies; Dyspepsia; Female; Gas | 1996 |
Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Cisapride; Diabetes Mellitus, Type 1; Erythromycin; Female; Gastric Emptying; Gastroparesis; | 1997 |
Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats.
Topics: Animals; Benzamides; Benzimidazoles; Blood Glucose; Cisapride; Diabetes Mellitus, Experimental; Gast | 1997 |
Postviral gastroparesis: presentation, treatment, and outcome.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cisapride; Female; Gastrointestinal Agents; Gast | 1997 |
Managing gastric stasis.
Topics: Cisapride; Drug Administration Routes; Gastrointestinal Agents; Gastroparesis; Humans; Piperidines | 1998 |
Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs.
Topics: Animals; Cisapride; Clonidine; Dogs; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Gastro | 1998 |
EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs.
Topics: Animals; Atropine; Cisapride; Dogs; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Gastrop | 2000 |
[Peripheral neuropathy in diabetes mellitus from the perspective of internist].
Topics: Cisapride; Diabetic Neuropathies; Drug and Narcotic Control; Drug Interactions; Gastrointestinal Age | 2000 |
Gastric emptying in diabetic gastroparetic dogs: ffects of SK-951,a novel prokinetic agent.
Topics: Acetaminophen; Animals; Benzofurans; Blood Glucose; Body Weight; Bridged Bicyclo Compounds, Heterocy | 2001 |